Professor Sarah Teichmann announced as new member of the American Academy of Arts & Sciences
24 April 2025
Professor Sarah Teichmann FMedSci FRS, Chair in Stem Cell Medicine at the University of Cambridge (Cambridge Stem Cell Institute & Dept Medicine), and Group Leader at CSCI, has been announced this week as one of the newest members of the prestigious American Academy of Arts & Sciences . Sarah says, “ It is a...
Groundbreaking discovery from Tzelepis Lab could revolutionise treatment for deadly blood cancers
23 April 2025
A new study from Dr Konstantinos Tzelepis at the Cambridge Stem Cell Institute has discovered a new way to detect and target Acute Myeloid Leukaemia (AML), a fast growing, aggressive, blood cancer that requires urgent treatment. The research was published today (23 April) in Nature Biotechnology. AML is the second most...
New research from Vassiliou Group shows diabetes drug may prevent aggressive leukaemia
17 April 2025
Research out this week from the Vassiliou and Huntly Groups shows that a common diabetes drug could prevent a form of acute myeloid leukaemia in people at high risk of the disease. The research, published 16 April in Nature , found that metformin, a widely used and readily available diabetes drug, could prevent abnormal...
Rapid growth of blood cancer driven by a single genetic 'hit' in new paper from Nangalia Group
11 April 2025
Researchers have explored the evolution of the genetic change that causes chronic myeloid leukaemia and show its ability to drive the disease. A new study has unveiled when chronic myeloid leukaemia, a type of cancer that affects the blood and bone marrow, arises in life and how fast it grows. Researchers reveal explosive...